© 2021 MJH Life Sciences and OncLive. All rights reserved.
2 Clarke DriveSuite 100Cranbury, NJ 08512
© 2021 MJH Life Sciences™ and OncLive. All rights reserved.
Through the lens of multidisciplinary management in breast cancer, experts share practical insight on the identification and management of interstitial lung disease.
August 25th 2021
Experts reflect on the importance of multidisciplinary care and outline the many disciplines involved in diagnosing and treating breast cancer.
Comprehensive details on how multidisciplinary care is applied during a patient’s treatment journey, with a focus on pulmonology and critical care.
September 1st 2021
Shared insight on how nuanced multidisciplinary care can positively impact outcomes when treating a patient with breast cancer.
Focusing on the value of electronic systems and tumor boards, experts detail how best to communicate across disciplines in the management of breast cancer.
September 8th 2021
Key opinion leaders highlight the challenges inherent in using multidisciplinary care to manage breast cancer, particularly when a patient is seen at multiple institutions.
An overview of optimal multidisciplinary care for a patient who presents with HER2+ metastatic breast cancer.
September 15th 2021
In light of breast cancer therapies with the potential to cause interstitial lung disease, experts consider important patient risk factors and best monitoring practices.
Shared insight on the optimal management of patients who develop interstitial lung disease while receiving therapy for breast cancer.